Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Opioid Receptors: Overview01:22

Opioid Receptors: Overview

5.3K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
5.3K
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

1.2K
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.2K
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

1.2K
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
1.2K
Analgesia and Pain Management01:25

Analgesia and Pain Management

2.3K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
2.3K
Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

4.3K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
4.3K
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents01:17

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

764
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
764

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Modular synthesis and bioevaluation of novel fused-β-carbolines as kappa opioid receptor modulators.

European journal of medicinal chemistry·2026
Same author

Pharmacological inhibition of IRAK1/4 ameliorates high-fat diet-induced vascular dysfunction and cognitive impairment.

Molecular biology reports·2026
Same author

Synthesis and Evaluation of Novel Aza-Aromatics as Dual 5‑HT2A and 5‑HT2C Receptor Agonists.

ACS medicinal chemistry letters·2025
Same author

Novel bis(triazole) analogues as selective TGR5 agonists with anti-diabesity effects.

Bioorganic chemistry·2025
Same author

Towards next-generation 5-hydroxytryptamine 2C receptor modulators: Greener synthesis and evaluation of novel isocoumarin derivatives as PAAMs of 5-HT<sub>2C</sub>R.

Bioorganic chemistry·2025
Same author

Reciprocal regulation of the H<sub>3</sub> histamine receptor in Rett syndrome and <i>MECP2</i> Duplication syndrome: implications for therapeutic development.

bioRxiv : the preprint server for biology·2025

Related Experiment Video

Updated: Feb 26, 2026

Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents
07:05

Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents

Published on: September 10, 2018

6.5K

Opioid Receptor Modulators with a Cinnamyl Group.

Lokesh Ravilla1,2, N Venkata Subba Naidu2, Shalini Dogra3

  • 1R&D Centre, Alkem Laboratories Ltd. , Peenya Ind. Area, 3rd Stage, Bangalore 560 058, India.

Journal of Medicinal Chemistry
|July 21, 2017
PubMed
Summary

Researchers developed novel opioid receptor ligands, identifying specific mu-opioid receptor (MOR) antagonists and kappa-opioid receptor (KOR) agonists. Some compounds demonstrated analgesic effects, offering potential for new pain management therapies.

More Related Videos

Preparation and Delivery of Protein Microcrystals in Lipidic Cubic Phase for Serial Femtosecond Crystallography
09:09

Preparation and Delivery of Protein Microcrystals in Lipidic Cubic Phase for Serial Femtosecond Crystallography

Published on: September 20, 2016

12.0K
Tracking Drug-induced Changes in Receptor Post-internalization Trafficking by Colocalizational Analysis
07:48

Tracking Drug-induced Changes in Receptor Post-internalization Trafficking by Colocalizational Analysis

Published on: July 3, 2015

9.3K

Related Experiment Videos

Last Updated: Feb 26, 2026

Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents
07:05

Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents

Published on: September 10, 2018

6.5K
Preparation and Delivery of Protein Microcrystals in Lipidic Cubic Phase for Serial Femtosecond Crystallography
09:09

Preparation and Delivery of Protein Microcrystals in Lipidic Cubic Phase for Serial Femtosecond Crystallography

Published on: September 20, 2016

12.0K
Tracking Drug-induced Changes in Receptor Post-internalization Trafficking by Colocalizational Analysis
07:48

Tracking Drug-induced Changes in Receptor Post-internalization Trafficking by Colocalizational Analysis

Published on: July 3, 2015

9.3K

Area of Science:

  • Medicinal Chemistry
  • Pharmacology
  • Neuroscience

Background:

  • Opioid receptors are critical targets for pain management.
  • Developing selective ligands for opioid receptors remains a challenge.
  • Alvimopan is a known mu-opioid receptor (MOR) antagonist.

Purpose of the Study:

  • To synthesize novel dehydro derivatives of alvimopan and related compounds.
  • To investigate the selectivity and potency of these new compounds at opioid receptors (MOR, DOR, KOR).
  • To explore potential analgesic properties and mechanisms of action.

Main Methods:

  • Chemical synthesis of dehydro alvimopan derivatives and arylpiperazines/piperidines.
  • In vitro receptor binding assays to determine affinity and selectivity.
  • In vivo analgesic testing using the tail flick test.
  • Molecular docking studies to rationalize observed activities.

Main Results:

  • Compound 28f showed selective but modest MOR antagonism.
  • Arylpiperazine derivatives (e.g., 13h) exhibited KOR agonism with no MOR/DOR activity.
  • Specific MOR antagonists, including 28g and 26b (more potent than naloxone), were identified within the arylpiperidine series.
  • Compounds 13l and 11b demonstrated analgesic effects blocked by norbinaltorphimine (norBNI), indicating KOR involvement.
  • Docking studies provided insights into the structure-activity relationships.

Conclusions:

  • Novel selective MOR antagonists and KOR agonists were successfully synthesized.
  • The structural modifications influenced opioid receptor subtype selectivity.
  • Compounds with KOR-mediated analgesic effects were identified, warranting further investigation.
  • Molecular docking aids in understanding the differential activities of these ligands.